IP Library Granted Patent US 8,022,184
Granted Patent B2
US 8,022,184 · App. 12/871,231 · Granted Sep 20, 2011

IFBM's to promote the specific attachment of target analytes to the surface of orthopedic implants

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,022,184
App. No.
12/871,231
Granted
Sep 20, 2011
Kind
B2
Abstract

The present invention provides an improved coating for surfaces of medical implants. The coating comprises at least one interfacial biomaterial (IFBM) which is comprised of at least one binding module that binds to the surface of an implant or implant-related material (“implant module”) and at least one binding module that selectively binds to a target analyte or that is designed to have a desired effect (“analyte module”). The modules are connected by a linker. In some embodiments, the IFBM coating acts to promote the recognition and attachment of target analytes to surface of the device. The IFBM coating improves the performance of implanted medical devices, for example, by promoting osteointegration of the implant.

Claims (10)

1. A binding module comprising a polypeptide selected from the group consisting of SEQ ID NOs: 82-84, 86, 88-89, and 91-92, or a conservatively substituted variant thereof, wherein the binding module binds to a bone morphogenetic protein.

2. A binding module comprising a polypeptide that binds to bone morphogenetic protein-2, wherein the polypeptide comprises:

(i) a sequence that is at least 70% identical to any one of the sequences set forth in SEQ ID NOs: 82-84, 86, 88-89, and 91-92;

(ii) a sequence that is at least 75% identical to any one of the sequences set forth in SEQ ID NOs: 82-84, 86, 88-89, and 91-92;

(iii) a sequence that is at least 80% identical to any one of the sequences set forth in SEQ ID NOs: 82-84, 86, 88-89, and 91-92;

(iv) a sequence that is at least 85% identical to any one of the sequences set forth in SEQ ID NOs: 82-84, 86, 88-89, and 91-92;

(v) a sequence that is at least 90% identical to any one of the sequences set forth in SEQ ID NOs: 82-84, 86, 88-89, and 91-92; or

(vi) a sequence that is at least 95% identical to any one of the sequences set forth in SEQ ID NOs: 82-84, 86, 88-89, and 91-92.

3. The binding module of claim 1 or claim 2 , wherein the bone morphogenetic protein is bone morphogenetic protein-2.

4. An isolated nucleic acid comprising a nucleotide sequence encoding an amino acid sequence selected from the group consisting of SEQ ID NOs: 82-84, 86, 88-89, and 91-92, or a conservatively substituted variant thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2014
From: AFFINERGY, INC.
To: AFFINERGY, LLC
Reel/Frame 031920/0540 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2012
From: AFFINERGY, INC.
To: AFFINERGY, LLC.
Reel/Frame 027890/0225 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2010
From: BEYER, WAYNE F; HYDE-DERUYSCHER, ROBIN; HAMILTON, PAUL T; BENSON, RAY EDWARD
To: AFFINERGY, INC.
Reel/Frame 024955/0784 →